Monoclonal antibody basiliximab with low cyclosporine dose as initial immunosuppression

Transplant Proc. 2001 Nov-Dec;33(7-8):3184-6. doi: 10.1016/s0041-1345(01)02355-7.

Authors

J N Boletis¹, H Theodoropoulou, T Hiras, D Stamatiadis, M Darema, E Psimenou, C Stathakis, A Kostakis

Affiliation

¹ Department of Nephrology, Laiko General Hospital, Athens, Greece.

PMID: 11750366
DOI: 10.1016/s0041-1345(01)02355-7

No abstract available

MeSH terms

Adult
Antibodies, Monoclonal / therapeutic use*
Basiliximab
Creatinine / blood
Cyclosporine / blood
Cyclosporine / therapeutic use*
Cytomegalovirus Infections / prevention & control
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Graft Rejection / prevention & control*
Humans
Immunosuppressive Agents / therapeutic use
Kidney Transplantation / immunology*
Kidney Transplantation / physiology
Male
Methylprednisolone / therapeutic use
Postoperative Complications / prevention & control
Recombinant Fusion Proteins*

Substances

Antibodies, Monoclonal
Immunosuppressive Agents
Recombinant Fusion Proteins
Cyclosporine
Basiliximab
Creatinine
Methylprednisolone